Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.
HIV entry inhibitors.
Inter-population variability of DEFA3 gene absence: correlation with haplotype structure and population variability.
HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions.
Renal expression of parvalbumin is critical for NaCl handling and response to diuretics.
A whole-genome association study of major determinants for host control of HIV-1.
Longitudinal study on mitochondrial effects of didanosine-tenofovir combination.
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors.
Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.
[Resistance genotyping in patients with therapeutic failure].